MYLLE PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MYLLE PHARMA
Largest movements
- Cash -€16,718
down €16,718 (-17.6%), from €95,104 to €78,386
mainly Contributions, distributions and other (-€240,000) and Debts after one year (-€46,806)
- Other debts +€140,358
up €140,358 (+411%), from €34,179 to €174,536
- Reserves -€111,810
down €111,810 (-19.6%), from €571,781 to €459,971
- Debts after one year -€46,806
down €46,806 (-17.4%), from €269,616 to €222,810
- Financial income +€50,054
up €50,054 (+100%), from €50,000 to €100,054
- Gross operating margin -€10,119
down €10,119 (-12.9%), from €78,597 to €68,478
- Taxes +€2,031
up €2,031 (+9.3%), from €21,873 to €23,904
- Financial charges -€1,199
down €1,199 (-9.7%), from €12,358 to €11,158
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €963,065 | €947,525 | -€15,540 | -1.6% |
| Fixed assets | 21/28 | €867,019 | €868,324 | +€1,305 | +0.2% |
| Tangible fixed assets | 22/27 | €7,019 | €8,324 | +€1,305 | +18.6% |
| Furniture and vehicles | 24 | €7,019 | €8,324 | +€1,305 | +18.6% |
| Financial fixed assets | 28 | €860,000 | €860,000 | = | 0.0% |
| Current assets | 29/58 | €96,045 | €79,201 | -€16,845 | -17.5% |
| Amounts receivable within one year | 40/41 | €81 | - | -€81 | |
| Trade receivables | 40 | €10 | - | -€10 | |
| Other amounts receivable | 41 | €71 | - | -€71 | |
| Cash at bank and in hand | 54/58 | €95,104 | €78,386 | -€16,718 | -17.6% |
| Deferred charges and accrued income | 490/1 | €860 | €814 | -€46 | -5.3% |
| Total equity and liabilities | 10/49 | €963,065 | €947,525 | -€15,540 | -1.6% |
| Equity | 10/15 | €590,381 | €478,571 | -€111,810 | -18.9% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €571,781 | €459,971 | -€111,810 | -19.6% |
| Distributable reserves | 133 | €571,781 | €459,971 | -€111,810 | -19.6% |
| Amounts payable | 17/49 | €372,684 | €468,953 | +€96,270 | +25.8% |
| Amounts payable after more than one year | 17 | €269,616 | €222,810 | -€46,806 | -17.4% |
| Financial debts | 170/4 | €269,616 | €222,810 | -€46,806 | -17.4% |
| Amounts payable within one year | 42/48 | €103,068 | €246,144 | +€143,076 | +139% |
| Current portion of amounts payable after more than one year | 42 | €46,007 | €46,806 | +€799 | +1.7% |
| Trade debts | 44 | €3,663 | €3,058 | -€605 | -16.5% |
| Suppliers | 440/4 | €3,663 | €3,058 | -€605 | -16.5% |
| Taxes, remuneration and social security | 45 | €19,220 | €21,744 | +€2,524 | +13.1% |
| Taxes | 450/3 | €19,220 | €21,744 | +€2,524 | +13.1% |
| Other amounts payable | 47/48 | €34,179 | €174,536 | +€140,358 | +411% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,211 | €2,404 | +€193 | +8.7% |
| Other operating charges | 640/8 | €3,394 | €2,875 | -€519 | -15.3% |
| Gross operating margin | 9900 | €78,597 | €68,478 | -€10,119 | -12.9% |
| Operating profit (loss) | 9901 | €72,992 | €63,199 | -€9,793 | -13.4% |
| Financial income | 75/76B | €50,000 | €100,054 | +€50,054 | +100% |
| Recurring financial income | 75 | €50,000 | €100,054 | +€50,054 | +100% |
| Financial charges | 65/66B | €12,358 | €11,158 | -€1,199 | -9.7% |
| Recurring financial charges | 65 | €12,358 | €11,158 | -€1,199 | -9.7% |
| Profit (loss) for the period before taxes | 9903 | €110,634 | €152,094 | +€41,460 | +37.5% |
| Income taxes | 67/77 | €21,873 | €23,904 | +€2,031 | +9.3% |
| Profit (loss) for the period | 9904 | €88,761 | €128,190 | +€39,430 | +44.4% |
| Profit (loss) for the period to be appropriated | 9905 | €88,761 | €128,190 | +€39,430 | +44.4% |
Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.